Synthetic peptide mapping to the N terminus of human BRCA2.
Our Abpromise guarantee covers the use of ab27976 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 - 4 µg/ml. Predicted molecular weight: 384 kDa.Can be blocked with BRCA2 peptide (ab69799).|
|IP||Use at an assay dependent concentration. PubMed: 24210700|
|IHC-P||Use at an assay dependent concentration.|